Literature DB >> 21439440

The immunopathophysiology of multiple sclerosis.

Gregory F Wu1, Enrique Alvarez.   

Abstract

This review explores the principle features of the immunopathology of multiple sclerosis (MS), particularly relapsing-remitting MS. It highlights the emerging concepts in the pathogenesis of MS in the context of known features of pathology, including the characterization of cytokine networks promoting inflammatory damage of the central nervous system, B-cell involvement, and inflammatory damage of axons and neurons. This article preferentially focuses on MS rather than animal models of the disease, such as experimental autoimmune encephalomyelitis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439440      PMCID: PMC3080042          DOI: 10.1016/j.ncl.2010.12.009

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  137 in total

1.  Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes.

Authors:  I Medana; M A Martinic; H Wekerle; H Neumann
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.

Authors:  K W Wucherpfennig; I Catz; S Hausmann; J L Strominger; L Steinman; K G Warren
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands.

Authors:  I Bosca; L M Villar; F Coret; M J Magraner; M Simó-Castelló; J C Alvarez-Cermeño; B Casanova
Journal:  Mult Scler       Date:  2010-06-10       Impact factor: 6.312

4.  Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

Authors:  Melanie Greter; Frank L Heppner; Maria P Lemos; Bernhard M Odermatt; Norbert Goebels; Terri Laufer; Randolph J Noelle; Burkhard Becher
Journal:  Nat Med       Date:  2005-02-27       Impact factor: 53.440

5.  Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

Authors:  Eileen J McMahon; Samantha L Bailey; Carol Vanderlugt Castenada; Hanspeter Waldner; Stephen D Miller
Journal:  Nat Med       Date:  2005-02-27       Impact factor: 53.440

Review 6.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

7.  Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis.

Authors:  Maria V Tejada-Simon; Ying C Q Zang; Jian Hong; Victor M Rivera; Jingwu Z Zhang
Journal:  Ann Neurol       Date:  2003-02       Impact factor: 10.422

8.  Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation.

Authors:  Laura Piccio; Cecilia Buonsanti; Marina Cella; Ilaria Tassi; Robert E Schmidt; Chiara Fenoglio; John Rinker; Robert T Naismith; Paola Panina-Bordignon; Nadia Passini; Daniela Galimberti; Elio Scarpini; Marco Colonna; Anne H Cross
Journal:  Brain       Date:  2008-09-12       Impact factor: 13.501

9.  CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.

Authors:  Bing Zhu; Yoshio Bando; Sheng Xiao; Kaiyong Yang; Ana C Anderson; Vijay K Kuchroo; Samia J Khoury
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

Review 10.  Axon-glial signaling and the glial support of axon function.

Authors:  Klaus-Armin Nave; Bruce D Trapp
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

View more
  49 in total

1.  Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse.

Authors:  Honghao Wang; Kai Wang; Xiaonan Zhong; Wei Qiu; Yongqiang Dai; Aimin Wu; Xueqiang Hu
Journal:  J Clin Immunol       Date:  2012-05-30       Impact factor: 8.317

2.  Catalpol induces oligodendrocyte precursor cell-mediated remyelination in vitro.

Authors:  Chun-Xiao Yuan; Takho Chu; Li Liu; Hao-Wen Li; Ya-Jie Wang; An-Chen Guo; Yong-Ping Fan
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

Review 3.  Immune and autonomic nervous system interactions in multiple sclerosis: clinical implications.

Authors:  Mario Habek
Journal:  Clin Auton Res       Date:  2019-04-08       Impact factor: 4.435

4.  Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis.

Authors:  Vanitha A Jagannath; Eugenio Pucci; Govindaraj V Asokan; Edward W Robak
Journal:  Cochrane Database Syst Rev       Date:  2019-05-31

5.  Vaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis.

Authors:  Barlas Büyüktimkin; Qun Wang; Paul Kiptoo; John M Stewart; Cory Berkland; Teruna J Siahaan
Journal:  Mol Pharm       Date:  2012-03-13       Impact factor: 4.939

Review 6.  Control of autoimmune inflammation by celastrol, a natural triterpenoid.

Authors:  Shivaprasad H Venkatesha; Steven Dudics; Brian Astry; Kamal D Moudgil
Journal:  Pathog Dis       Date:  2016-07-11       Impact factor: 3.166

7.  The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.

Authors:  Salih Hamcan; Bilal Battal; Veysel Akgun; Oguzhan Oz; Yalcin Bozkurt; Serdar Tasdemir; Sebahattin Sari; Mustafa Tasar
Journal:  Eur Radiol       Date:  2016-04-23       Impact factor: 5.315

8.  B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.

Authors:  Chelsea R Parker Harp; Angela S Archambault; Julia Sim; Stephen T Ferris; Robert J Mikesell; Pandelakis A Koni; Michiko Shimoda; Christopher Linington; John H Russell; Gregory F Wu
Journal:  J Immunol       Date:  2015-04-20       Impact factor: 5.422

9.  Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases.

Authors:  Gregory F Wu; Chelsea R Parker Harp; Kenneth S Shindler
Journal:  Curr Immunol Rev       Date:  2015

10.  Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.

Authors:  D Pisa; R Alonso; F J Jiménez-Jiménez; L Carrasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-16       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.